795 related articles for article (PubMed ID: 31585308)
41.
Zhang L; Yang S; Wong LR; Xie H; Ho PC
Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
[TBL] [Abstract][Full Text] [Related]
42. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
[TBL] [Abstract][Full Text] [Related]
43. Chitosan/carboxymethylcellulose-stabilized poly(lactide-co-glycolide) particles as bio-based drug delivery carriers.
Inphonlek S; Sunintaboon P; Léonard M; Durand A
Carbohydr Polym; 2020 Aug; 242():116417. PubMed ID: 32564826
[TBL] [Abstract][Full Text] [Related]
44. GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma.
Borah A; Pillai SC; Rochani AK; Palaninathan V; Nakajima Y; Maekawa T; Kumar DS
Nanotechnology; 2020 May; 31(18):185102. PubMed ID: 31952056
[TBL] [Abstract][Full Text] [Related]
45. Microfluidic Assisted Nanoprecipitation of PLGA Nanoparticles for Curcumin Delivery to Leukemia Jurkat Cells.
Leung MHM; Shen AQ
Langmuir; 2018 Apr; 34(13):3961-3970. PubMed ID: 29544247
[TBL] [Abstract][Full Text] [Related]
46. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
[TBL] [Abstract][Full Text] [Related]
47. Selection and Control of Process Conditions Enable the Preparation of Curcumin-Loaded Poly(lactic-
Feltrin FDS; D'Angelo NA; Guarnieri JPO; Lopes AM; Lancellotti M; Lona LMF
ACS Appl Mater Interfaces; 2023 Jun; 15(22):26496-26509. PubMed ID: 37219485
[TBL] [Abstract][Full Text] [Related]
48. Gemcitabine Co-Encapsulated with Curcumin in Folate Decorated PLGA Nanoparticles; a Novel Approach to Treat Breast Adenocarcinoma.
Mukhopadhyay R; Sen R; Paul B; Kazi J; Ganguly S; Debnath MC
Pharm Res; 2020 Feb; 37(3):56. PubMed ID: 32072346
[TBL] [Abstract][Full Text] [Related]
49. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
[TBL] [Abstract][Full Text] [Related]
50. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues.
Huang Y; Canup BSB; Gou S; Chen N; Dai F; Xiao B; Li C
J Mater Chem B; 2021 Feb; 9(6):1604-1615. PubMed ID: 33471012
[TBL] [Abstract][Full Text] [Related]
51. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
Lin M; Teng L; Wang Y; Zhang J; Sun X
Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
[TBL] [Abstract][Full Text] [Related]
52. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.
Wang WY; Cao YX; Zhou X; Wei B
Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632
[No Abstract] [Full Text] [Related]
53. PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells.
Nosrati H; Adibtabar M; Sharafi A; Danafar H; Hamidreza Kheiri M
Drug Dev Ind Pharm; 2018 Aug; 44(8):1377-1384. PubMed ID: 29560737
[TBL] [Abstract][Full Text] [Related]
54. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice.
Murugesan K; Srinivasan P; Mahadeva R; Gupta CM; Haq W
Int J Nanomedicine; 2020; 15():10547-10559. PubMed ID: 33414637
[TBL] [Abstract][Full Text] [Related]
55. Formulation, Characterization and Biological Activity Screening of Sodium Alginate-Gum Arabic Nanoparticles Loaded with Curcumin.
Hassani A; Mahmood S; Enezei HH; Hussain SA; Hamad HA; Aldoghachi AF; Hagar A; Doolaanea AA; Ibrahim WN
Molecules; 2020 May; 25(9):. PubMed ID: 32397633
[TBL] [Abstract][Full Text] [Related]
56. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
[TBL] [Abstract][Full Text] [Related]
57. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
58. Curcumin-loaded PLGA nanoparticles conjugated with anti- P-glycoprotein antibody to overcome multidrug resistance.
Punfa W; Suzuki S; Pitchakarn P; Yodkeeree S; Naiki T; Takahashi S; Limtrakul P
Asian Pac J Cancer Prev; 2014; 15(21):9249-58. PubMed ID: 25422208
[TBL] [Abstract][Full Text] [Related]
59. Nanoparticles based on oleate alginate ester as curcumin delivery system.
Raja MA; Liu C; Huang Z
Curr Drug Deliv; 2015; 12(5):613-27. PubMed ID: 25963307
[TBL] [Abstract][Full Text] [Related]
60. "Watson-Crick G[triple bond, length as m-dash]C"-inspired supramolecular nanodrug of methotrexate and 5-fluorouracil for tumor microenvironment-activatable self-recognizing synergistic chemotherapy.
Chen M; Chen S; Zhu F; Wang F; Tian H; Fan Z; Ke S; Hou Z; Li Y
J Mater Chem B; 2020 May; 8(17):3829-3841. PubMed ID: 32232285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
